The RNA world in the 21st century-a systems approach to finding non-coding keys to clinical questions

Briefings in Bioinformatics

Volumn 17, Issue 3, 2016, Pages 380-392

  Schmitz, Ulf ^a   Naderi Meshkin, Hojjat ^b   Gupta, Shailendra K ^c,d   Wolkenhauer, Olaf ^c   Vera, Julio ^e  

^a UNIVERSITY OF SYDNEY   (Australia)

^b AVICENNA RESEARCH INSTITUTE   (Iran)

^c UNIVERSITY OF ROSTOCK   (Germany)

^d CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^e UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

lncRNA; miRNA; ncRNA network modeling; RNA function prediction; RNA systems medicine; Target prediction

Indexed keywords

RNA;

GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN; SEQUENCE ANALYSIS; SYSTEM ANALYSIS;

HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; RNA; SEQUENCE ANALYSIS, RNA; SYSTEMS ANALYSIS;

EID: 84971671462     PISSN: 14675463     EISSN: 14774054     Source Type: Journal    
DOI: 10.1093/bib/bbv061     Document Type: Article

References (158)

1. Gardner PP, Giegerich R. A comprehensive comparison of comparative RNA structure prediction approaches. BMC Bioinformatics 2004;5:140.
2. Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 2008;9:102-14.
3. Leung AKL, Sharp PA. microRNAs: a safeguard against turmoil? Cell 2007;130:581-5.
4. Zare H, Khodursky A, Sartorelli V. An evolutionarily biased distribution of miRNA sites toward regulatory genes with high promoter-driven intrinsic transcriptional noise. BMC Evol Biol 2014;14:74.
5. Thum T, Gross C, Fiedler J, et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008;456:980-4.
6. Farazi TA, Hoell JI, Morozov P, et al. MicroRNAs in human cancer. MicroRNA Cancer Regul 2013;774:1-20.
7. Calin GA, Croce CM. MicroRNA-cancer connection: the beginning of a new tale. Cancer Res 2006;66:7390-4.
8. Bushati N, Cohen SM. microRNA functions. Annu Rev Cell Dev Biol 2007;23:175-205.
9. Li Y, Qiu C, Tu J, et al. HMDD v2.0: a database for experimentally supported human microRNA and disease associations. Nucleic Acids Res 2014;42:D1070-4.
10. Kozomara A, Griffiths-Jones S. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res 2014;42:D68-73.
11. Chang TC, Mendell JT. microRNAs in vertebrate physiology and human disease. Annu Rev Genomics Hum Genet 2007;8:215-39.
12. Miranda KC, Huynh T, Tay Y, et al. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 2006;126:1203-17.
13. Selbach M, Schwanhäusser B, Thierfelder N, et al. Widespread changes in protein synthesis induced by microRNAs. Nature 2008;455:58-63.
14. Gabriely G, Wurdinger T, Kesari S, et al. MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol 2008;28:5369-80.
15. Jiang Q, Feng MG, Mo YY. Systematic validation of predicted microRNAs for cyclin D1. BMC Cancer 2009;9:194.
16. Derrien T, Johnson R, Bussotti G, et al. TheGENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res 2012;22:1775-89.
17. Shi X, Sun M, Liu H, et al. Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett 2013;339:159-66.
18. Harrow J, Frankish A, Gonzalez JM, et al. GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res 2012;22:1760-74.
19. Wilusz JE, Sunwoo H, Spector DL. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev 2009;23:1494-504.
20. Clark BS, Blackshaw S. Long non-coding RNA-dependent transcriptional regulation in neuronal development and disease. Front Genet 2014;5:164.
21. Hu W, Alvarez-Dominguez JR, Lodish HF. Regulation of mammalian cell differentiation by long non-coding RNAs. EMBO Rep 2012;13:971-83.
22. Shore AN, Rosen JM. Regulation of mammary epithelial cell homeostasis by lncRNAs. Int J BiochemCell Biol 2014;54:318-30.
23. Wang KC, Yang YW, Liu B, et al. A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature 2011;472:120-4.
24. McCann KL, Baserga SJ. Long noncoding RNAs as sinks in Prader-Willi syndrome. Mol Cell 2012;48:155-7.
25. Ogawa Y, Sun BK, Lee JT. Intersection of the RNA interference and X-inactivation pathways. Science 2008;320:1336-41.
26. Rapicavoli NA, Qu K, Zhang J, et al. A mammalian pseudogene lncRNA at the interface of inflammation and antiinflammatory therapeutics. Elife 2013;2:e00762.
27. Shamovsky I, Ivannikov M, Kandel ES, et al. RNA-mediated response to heat shock in mammalian cells. Nature 2006;440:556-60.
28. Luo M, Jeong M, Sun D, et al. Long non-coding RNAs control hematopoietic stem cell function. Cell Stem Cell 2015;16:426-38 doi: 10.1016/j.stem.2015.02.002.
29. Gordiiuk VV. Long non-coding RNAs-'tuning fork' in regulation of cell processes. Ukr Biokhim Zh 2014;86:5-15.
30. Li CH, Chen Y. Targeting long non-coding RNAs in cancers: progress and prospects. Int J Biochem Cell Biol 2013;45:1895-910.
31. Wang X, Arai S, Song X, et al. Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature 2008;454:126-30.
32. Tsai MC, Manor O, Wan Y, et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010;329:689-93.
33. Batista PJ, Chang HY. Cytotopic localization by long noncoding RNAs. Curr Opin Cell Biol 2013;25:195-9.
34. Feng J, Bi C, Clark BS, et al. The Evf-2 noncoding RNA is transcribed from the Dlx-5/6 ultraconserved region and functions as a Dlx-2 transcriptional coactivator. Genes Dev 2006;20:1470-84.
35. Hung T, Wang Y, Lin MF, et al. Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat Genet 2011;43:621-9.
36. Leucci E, Patella F, Waage J, et al. microRNA-9 targets the long non-coding RNA MALAT1 for degradation in the nucleus. Sci Rep 2013;3:2535.
37. Poliseno L, Salmena L, Zhang J, et al. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 2010;465:1033-8.
38. Salmena L, Poliseno L, Tay Y, et al. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 2011;146:353-8.
39. Faghihi MA, Zhang M, Huang J, et al. Evidence for natural antisense transcript-mediated inhibition of microRNA function. Genome Biol 2010;11:R56.
40. Rogler LE, Kosmyna B, Moskowitz D, et al. Small RNAs derived from lncRNA RNase MRP have gene-silencing activity relevant to human cartilage-hair hypoplasia. Hum Mol Genet 2014;23:368-82.
41. Mariner PD, Walters RD, Espinoza CA, et al. Human Alu RNA is a modular transacting repressor of mRNA transcription during heat shock. Mol Cell 2008;29:499-509.
42. Willingham AT. A strategy for probing the function of noncoding RNAs finds a repressor of NFAT. Science 2005;309:1570-3.
43. Osato N, Suzuki Y, Ikeo K, et al. Transcriptional interferences in cis natural antisense transcripts of humans and mice. Genetics 2007;176:1299-306.
44. Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol 2012;9:703-19.
45. Li J, Chen Z, Tian L, et al. LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma. Gut 2014;63:1700-10.
46. Tsai MC, Spitale RC, Chang HY. Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res 2011;71:3-7.
47. Bhartiya D, Kapoor S, Jalali S, et al. Conceptual approaches for lncRNA drug discovery and future strategies. Expert Opin Drug Discov 2012;7:503-13.
48. Seto AG. The road toward microRNA therapeutics. Int J Biochem Cell Biol 2010;42:1298-305.
49. Kasinski AL, Slack FJ. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 2011;11:849-64.
50. Ueda T, Volinia S, Okumura H, et al. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 2010;11:136-46.
51. Bhattacharya A, Schmitz U, Raatz Y, et al. miR-638 promotes melanoma metastasis and protects melanoma cells from apoptosis and autophagy. Oncotarget 2015;6:2966-80.
52. Yanaihara N, Caplen N, Bowman E, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006;9:189-98.
53. Abeel T, Helleputte T, Van de Peer Y, et al. Robust biomarker identification for cancer diagnosis with ensemble feature selection methods. Bioinformatics 2009;26:392-8.
54. Ferracin M, Veronese A, Negrini M. Micromarkers: miRNAs in cancer diagnosis and prognosis. Expert Rev Mol Diagn 2010;10:297-308.
55. Zhao H, Shen J, Medico L, et al. A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS One 2010;5:e13735.
56. Bonfrate L, Altomare DF, Di Lena M, et al. MicroRNA in colorectal cancer: new perspectives for diagnosis, prognosis and treatment. J Gastrointest Liver Dis 2013;22:311-20.
57. Barbarotto E, Schmittgen TD, Calin GA. MicroRNAs and cancer: profile, profile, profile. Int J Cancer 2008;122:969-77.
58. Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008;18:997-1006.
59. Etheridge A, Lee I, Hood L, et al. Extracellular microRNA: a new source of biomarkers. Mutat Res 2011;717:85-90.
60. Kosaka N, Iguchi H, Ochiya T. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci 2010;101:2087-92.
61. Zampetaki A, Willeit P, Drozdov I, et al. Profiling of circulating microRNAs: from single biomarkers to re-wired networks. Cardiovasc Res 2011;93:555-62.
62. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008;105:10513-18.
63. Morozova O, Hirst M, Marra MA. Applications of new sequencing technologies for transcriptome analysis. Annu Rev Genomics Hum Genet 2009;10:135-51.
64. Wang Y, Ghaffari N, Johnson CD, et al. Evaluation of the coverage and depth of transcriptome by RNA-Seq in chickens. BMC Bioinformatics 2011;12:S5.
65. Oshlack A, Wakefield MJ. Transcript length bias in RNA-seq data confounds systems biology. Biol Direct 2009;4:14.
66. Li N, You X, Chen T, et al. Global profiling of miRNAs and the hairpin precursors: insights into miRNA processing and novel miRNA discovery. Nucleic Acids Res 2013;41:3619-34.
67. Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 2013;495:333-8.
68. Ulitsky I, Bartel DP. lincRNAs: genomics, evolution, and mechanisms. Cell 2013;154:26-46.
69. Garber M, Grabherr MG, Guttman M, et al. Computational methods for transcriptome annotation and quantification using RNA-seq. Nat Methods 2011;8:469-77.
70. Costa V, Angelini C, De Feis I, et al. Uncovering the complexity of transcriptomes with RNA-Seq. J Biomed Biotechnol 2010;2010:853916.
71. Chen X, Yan G-Y. Novel human lncRNA-disease association inference based on lncRNA expression profiles. Bioinformatics 2013;29:2617-24.
72. Yang JH, Li JH, Jiang S, et al. ChIPBase: a database for decoding the transcriptional regulation of long non-coding RNA and microRNA genes from ChIP-Seq data. Nucleic Acids Res 2013;41:D177-87.
73. Cho S, Jang I, Jun Y, et al. miRGator v3.0: a microRNA portal for deep sequencing, expression profiling and mRNA targeting. Nucleic Acids Res 2012;41:D252-7.
74. Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: archive for functional genomics data sets-update. Nucleic Acids Res 2013;41:D991-5.
75. Dinger ME, Pang KC, Mercer TR, et al. NRED: a database of long noncoding RNA expression. Nucleic Acids Res 2009;37:D122-6.
76. Schwarzenbach H, Hoon DSB, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 2011;11:426-37.
77. Ren X, Wang Y, Wang J, et al. A unified computational model for revealing and predicting subtle subtypes of cancers. BMC Bioinformatics 2012;13:70.
78. Cascione L, Ferro A, Giugno R, et al. Elucidating the role of microRNAs in cancer through data mining techniques. Adv Exp Med Biol 2013;774:291-315.
79. Gupta SK, Schmitz U. Bioinformatics analysis of high-throughput experiments. Recent Trends Biotechnol 2011;2:129-56.
80. Vera J, Wolkenhauer O, Schmitz U. Current achievements in cancer systems biology. eLS. 2014., John Wiley & Sons, Ltd: Chichester. DOI: 10.1002/9780470015902.a0025237.
81. Subramanian A. From the cover: gene set enrichment analysis: a knowledge-based approach for interpreting genomewide expression profiles. Proc Natl Acad Sci USA 2005;102:15545-50.
82. Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2008;37:1-13.
83. Quek XC, Thomson DW, Maag JL, et al. lncRNAdb v2.0: expanding the reference database for functional long noncoding RNAs. Nucleic Acids Res 2015;43:D168-73.
84. Xie C, Yuan J, Li H, et al. NONCODEv4: exploring the world of long non-coding RNA genes. Nucleic Acids Res 2014;42:D98-103.
85. Volders PJ, Helsens K, Wang X, et al. LNCipedia: a database for annotated human lncRNA transcript sequences and structures. Nucleic Acids Res 2012;41:D246-51.
86. Chen G, Wang Z, Wang D, et al. LncRNADisease: a database for long-non-coding RNA-associated diseases. Nucleic Acids Res 2012;41:D983-6.
87. Paraskevopoulou MD, Georgakilas G, Kostoulas N, et al. DIANA-LncBase: experimentally verified and computationally predicted microRNA targets on long non-coding RNAs. Nucleic Acids Res 2012;41:D239-45.
88. Jeggari A, Marks DS, Larsson E. miRcode: a map of putative microRNA target sites in the long non-coding transcriptome. Bioinformatics 2012;28(15):2062-3.
89. RNAcentral Consortium. RNAcentral: an international database of ncRNA sequences. Nucleic Acids Res 2015;43:D123-9.
90. Griffiths-Jones S. The microRNA registry. Nucleic Acids Res 2004;32:D109-11.
91. Betel D, WilsonM, Gabow A, et al. The microRNA.org resource: targets and expression. Nucleic Acids Res 2008;36:D149-53.
92. Sales G, Coppe A, Bisognin A, et al. MAGIA, a web-based tool for miRNA and Genes Integrated Analysis. Nucleic Acids Res 2010;38:W352-9.
93. Ulitsky I, Laurent LC, Shamir R. Towards computational prediction of microRNA function and activity. Nucleic Acids Res 2010;38:e160.
94. Schmitz U, Wolkenhauer O. Web resources for microRNA research. Adv Exp Med Biol 2013;774:225-50.
95. Laganà A, Forte S, Giudice A, et al. miRò: a miRNA knowledge base. Database Oxf 2009;2009:bap008
96. Brigand KL, Robbe-Sermesant K, Mari B, et al. MiRonTop: mining microRNAs targets across large scale gene expression studies. Bioinformatics 2010;26:3131-2.
97. Enright AJ, John B, Gaul U, et al. MicroRNA targets in Drosophila. Genome Biol 2003;5:R1.
98. Ritchie W, Rasko JEJ, Flamant S. MicroRNA target prediction and validation. MicroRNA Cancer Regul 2013;774:39-53.
99. Chi SW, Hannon GJ, Darnell RB. An alternative mode of microRNA target recognition. Nat Struct Mol Biol 2012;19:321-7.
100. Ritchie W, Flamant S, Rasko JEJ. Predicting microRNA targets and functions: traps for the unwary. Nat Methods 2009;6:397-8.
101. Fan X, Kurgan L. Comprehensive overview and assessment of computational prediction of microRNA targets in animals. Brief Bioinform 2015;16:780-94.
102. Muppirala UK, Lewis BA, Dobbs D. Computational tools for investigating RNA-protein interaction partners. J Comput Sci Syst Biol 2013;6:182-7.
103. Muppirala UK, Honavar VG, Dobbs D. Predicting RNA-protein interactions using only sequence information. BMC Bioinformatics 2011;12:489.
104. Agostini F, Zanzoni A, Klus P, et al. catRAPID omics: a web server for large-scale prediction of protein-RNA interactions. Bioinformatics 2013;29:2928-30.
105. Ye S, Yang L, Zhao X, et al. Bioinformatics method to predict two regulation mechanism: TF-miRNA-mRNA and lncRNAmiRNA-mRNA in pancreatic cancer. Cell Biochem Biophys 2014;70:1849-58.
106. Wang Y, Xu Z, Jiang J, et al. Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal. Dev Cell 2013;25:69-80.
107. Chan WL, Huang HD, Chang JG. lncRNAMap: a map of putative regulatory functions in the long non-coding transcriptome. Comput Biol Chem 2014;50:41-9.
108. Li J, Ma W, Zeng P, et al. LncTar: a tool for predicting the RNA targets of long noncoding RNAs. Brief. Bioinform. 2014:pii: bbu048.
109. He S, Zhang H, Liu H, et al. LongTarget: a tool to predict lncRNA DNA-binding motifs and binding sites via Hoogsteen base-pairing analysis. Bioinformatics 2015;31:178-186.
110. Li JH, Liu S, Zhou H, et al. starBase v2.0: decoding miRNAceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res 2014;42:D92-7.
111. Wang T, Xie Y, Xiao G. dCLIP: a computational approach for comparative CLIP-seq analyses. Genome Biol 2014;15:R11.
112. Reyes-Herrera PH, Ficarra E. Computational methods for CLIP-seq data processing. Bioinform Biol Insights 2014;8:199-207.
113. Zhu J, Fu H, Wu Y, et al. Function of lncRNAs and approaches to lncRNA-protein interactions. Sci China Life Sci 2013;56:876-85.
114. Liao Q, Xiao H, Bu D, et al. ncFANs: a web server for functional annotation of long non-coding RNAs. Nucleic Acids Res 2011;39:W118-24.
115. Liao Q, Liu C, Yuan X, et al. Large-scale prediction of long non-coding RNA functions in a coding-non-coding gene coexpression network. Nucleic Acids Res 2011;39:3864-78.
116. Guo X, Gao L, Liao Q, et al. Long non-coding RNAs function annotation: a global prediction method based on bi-colored networks. Nucleic Acids Res 2013;41:e35-35
117. Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 2008;9:559
118. Kemena C, Bussotti G, Capriotti E, et al. Using tertiary structure for the computation of highly accurate multiple RNA alignments with the SARA-Coffee package. Bioinformatics 2013;29:1112-19.
119. Sahraeian SME, Yoon BJ. PicXAA-Web: a web-based platform for non-progressive maximum expected accuracy alignment of multiple biological sequences. Nucleic Acids Res 2011;39:W8-12.
120. Di Tommaso P, Moretti S, Xenarios I, et al. T-Coffee: a web server for the multiple sequence alignment of protein and RNA sequences using structural information and homology extension. Nucleic Acids Res 2011;39:W13-17.
121. Harmanci AO, Sharma G, Mathews DH. Efficient pairwise RNA structure prediction using probabilistic alignment constraints in Dynalign. BMC Bioinformatics 2007;8:130.
122. Yonemoto H, Asai K, Hamada M. CentroidAlign-Web: a fast and accurate multiple aligner for long non-coding RNAs. Int J Mol Sci 2013;14:6144-56.
123. Hamada M, Sato K, Kiryu H, et al. CentroidAlign: fast and accurate aligner for structured RNAs by maximizing expected sum-of-pairs score. Bioinformatics 2009;25:3236-43.
124. Schmitz U, Wolkenhauer O, Vera J. MicroRNA Cancer regulation advanced concepts. Bioinform Syst Biol Tools 2013. (in press).
125. Licatalosi DD, Mele A, Fak JJ, et al. HITS-CLIP yields genomewide insights into brain alternative RNA processing. Nature 2008;456:464-9.
126. Hafner M, Landthaler M, Burger L, et al. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 2010;141:129-41.
127. Helwak A, Kudla G, Dudnakova T, et al. Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell 2013;153:654-65.
128. Eulalio A, Huntzinger E, Nishihara T, et al. Deadenylation is a widespread effect of miRNA regulation. RNA 2008;15:21-32.
129. Bandyopadhyay S, Bhattacharyya M. PuTmiR: a database for extracting neighboring transcription factors of human microRNAs. BMC Bioinformatics 2010;11:190.
130. Vera J, Schmitz U. Computational microRNA Biology. Encycl Syst Biol 2013;473-80.
131. Khanin R, Vinciotti V. Computational modeling of post-transcriptional gene regulation by microRNAs. J Comput. Biol J Comput Mol Cell Biol 2008;15:305-16.
132. Agirre X, Vilas-Zornoza A, Jiménez-Velasco A, et al. Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia. Cancer Res 2009;69:4443-53.
133. Furuta M, Kozaki K, Tanaka S, et al. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 2010;31:766-76.
134. Lee Y, Yang X, Huang Y, et al. Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis. PLoS Comput Biol 2010;6:e1000730.
135. Aguda BD, Kim Y, Piper-Hunter MG, et al. MicroRNA regulation of a cancer network: consequences of the feedback loops involving miR-17-92, E2F, and Myc. Proc Natl Acad Sci USA 2008;105:19678-83.
136. Vohradsky J, Panek J, Vomastek T. Numerical modelling of microRNA-mediated mRNA decay identifies novel mechanism of microRNA controlled mRNA downregulation. Nucleic Acids Res 2010;38:4579-85.
137. Vera J, Schmitz U, Lai X, et al. Kinetic modeling-based detection of genetic signatures that provide chemoresistance via the E2F1-p73/DNp73-miR-205 network. Cancer Res 2013;73:3511-24.
138. Cui Q, Yu Z, Purisima EO, et al. Principles of microRNA regulation of a human cellular signaling network. Mol Syst Biol 2006;2:46.
139. Saetrom P, Heale BSE, Snøve O, et al. Distance constraints between microRNA target sites dictate efficacy and cooperativity. Nucleic Acids Res 2007;35:2333-42.
140. Lai X, Wolkenhauer O, Vera J. Modeling miRNA regulation in cancer signaling systems: miR-34a regulation of the p53/Sirt1 signaling module. Methods Mol Biol 2012;880:87-108.
141. Lai X, Bhattacharya A, Schmitz U, et al. A systems' biology approach to study microRNA-mediated gene regulatory networks. BioMed Res Int 2013;2013:703849.
142. Schmitz U, Lai X, Winter F, et al. Cooperative gene regulation by microRNA pairs and their identification using a computational workflow. Nucleic Acids Res 2014;42:7539-52.
143. Kallen AN, Zhou XB, Xu J, et al. The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell 2013;52:101-12.
144. Nissan T, Parker R. Computational analysis of miRNA-mediated repression of translation: implications for models of translation initiation inhibition. RNA 2008;14:1480-91.
145. Whichard ZL, Motter AE, Stein PJ, et al. Slowly produced microRNAs control protein levels. J Biol Chem 2011;286:4742-8.
146. Morozova N, Zinovyev A, Nonne N, et al. Kinetic signatures of microRNA modes of action. RNA 2012;18:1635-55.
147. Le Bechec A, Portales-Casamar E, Vettter G, et al. MIR@NT@N: a framework integrating transcription factors, microRNAs and their targets to identify sub-network motifs in metaregulation networkmodel. BMC Bioinformatics 2011;12:67.
148. Huang GT, Athanassiou C, Benos PV. mirConnX: conditionspecific mRNA-microRNA network integrator. Nucleic Acids Res 2011;39:W416-23.
149. Schulz MH, Pandit KV, Cardenas CLL, et al. Reconstructing dynamic microRNA-regulated interaction networks. Proc Natl Acad Sci USA 2013;110:15686-91.
150. Chiu HS, Llobet-Navas D, Yang X, et al. Cupid: simultaneous reconstruction of microRNA-target and ceRNA networks. Genome Res 2015;25(2):257-67.
151. Liu Z, Shen J, Wang R, et al. Dynamics of microRNA-mediated motifs. IET Syst Biol 2009;3:496-504.
152. Mukherji S, Ebert MS, Zheng GXY, et al. MicroRNAs can generate thresholds in target gene expression. Nat Genet 2011;43:854-9.
153. Zhou P, Cai S, Liu Z, et al. Mechanisms generating bistability and oscillations in microRNA-mediated motifs. Phys Rev E Stat Nonlin Soft Matter Phys 2012;85:041916.
154. Goyenvalle A, Babbs A, van Ommen GJB, et al. Enhanced exon-skipping Induced by U7 snRNA carrying a splicing silencer sequence: promising tool for DMD therapy. Mol Ther 2009;17:1234-40.
155. Baraniskin A, Nöpel-Dünnebacke S, Ahrens M, et al. Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for pancreatic and colorectal adenocarcinoma. Int J Cancer 2013;132:E48-57.
156. Han BW, Chen YQ. Potential pathological and functional links between long noncoding RNAs and hematopoiesis. Sci Signal 2013;6:re5.
157. Wright PR, Georg J, Mann M, et al. CopraRNA and IntaRNA: predicting small RNA targets, networks and interaction domains. Nucleic Acids Res 2014;42:W119-23.
158. Bonnici V, Russo F, Bombieri N, et al. Comprehensive reconstruction and visualization of non-coding regulatory networks in human. Front Bioeng Biotechnol 2014;2:69.